PRQR logo

ProQR Therapeutics NV (PRQR) Accounts Payable

Annual Accounts Payable

$1.70 M
+$1.28 M+305.19%

December 31, 2023


Summary


Performance

PRQR Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Quarterly Accounts Payable

$34.60 K
-$800.00-2.26%

September 1, 2024


Summary


Performance

PRQR Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

PRQR Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+305.2%0.0%
3 y3 years+526.7%-91.7%
5 y5 years+1003.2%-91.7%

PRQR Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+687.5%-98.0%at low
5 y5-yearat high+687.5%-98.0%at low
alltimeall timeat high+1256.2%-98.7%at low

ProQR Therapeutics NV Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$34.60 K(-2.3%)
Jun 2024
-
$35.40 K(-90.1%)
Mar 2024
-
$357.40 K(-79.0%)
Dec 2023
$1.70 M(+305.2%)
$1.70 M(+1275.9%)
Sep 2023
-
$123.80 K(-4.3%)
Jun 2023
-
$129.30 K(-57.0%)
Mar 2023
-
$301.00 K(-28.4%)
Dec 2022
$420.40 K(+94.4%)
$420.40 K(+0.6%)
Sep 2022
-
$417.70 K(-47.9%)
Jun 2022
-
$801.20 K(-12.9%)
Mar 2022
-
$919.70 K(+325.2%)
Dec 2021
$216.30 K(-20.4%)
$216.30 K(-79.1%)
Sep 2021
-
$1.04 M(+215.8%)
Jun 2021
-
$328.40 K(+1.9%)
Mar 2021
-
$322.40 K(+18.6%)
Dec 2020
$271.80 K(-45.5%)
$271.80 K(-20.4%)
Sep 2020
-
$341.60 K(-38.3%)
Jun 2020
-
$553.30 K(-13.2%)
Mar 2020
-
$637.50 K(+27.9%)
Dec 2019
$498.50 K
$498.50 K(-31.8%)
Sep 2019
-
$730.90 K(+241.9%)
Jun 2019
-
$213.80 K(+197.4%)
DateAnnualQuarterly
Mar 2019
-
$71.90 K(-53.4%)
Dec 2018
$154.40 K(-76.4%)
$154.40 K(-82.8%)
Sep 2018
-
$895.90 K(+253.8%)
Jun 2018
-
$253.20 K(+39.7%)
Mar 2018
-
$181.20 K(-72.3%)
Dec 2017
$655.00 K(+88.9%)
$655.00 K(+122.4%)
Sep 2017
-
$294.50 K(+14.9%)
Jun 2017
-
$256.20 K(+35.5%)
Mar 2017
-
$189.10 K(-45.5%)
Dec 2016
$346.70 K(-64.2%)
$346.70 K(+30.4%)
Sep 2016
-
$265.90 K(-77.0%)
Jun 2016
-
$1.15 M(-0.7%)
Mar 2016
-
$1.16 M(+20.2%)
Dec 2015
$967.60 K(-36.2%)
$967.60 K(+777.2%)
Sep 2015
-
$110.30 K(-89.0%)
Jun 2015
-
$1.00 M(-61.7%)
Mar 2015
-
$2.61 M(+72.3%)
Dec 2014
$1.52 M(+47.4%)
$1.52 M(+8.3%)
Sep 2014
-
$1.40 M(+15.8%)
Jun 2014
-
$1.21 M(+17.5%)
Dec 2013
$1.03 M(+719.0%)
$1.03 M
Dec 2012
$125.60 K
-

FAQ

  • What is ProQR Therapeutics NV annual accounts payable?
  • What is the all time high annual accounts payable for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual accounts payable year-on-year change?
  • What is ProQR Therapeutics NV quarterly accounts payable?
  • What is the all time high quarterly accounts payable for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly accounts payable year-on-year change?

What is ProQR Therapeutics NV annual accounts payable?

The current annual accounts payable of PRQR is $1.70 M

What is the all time high annual accounts payable for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual accounts payable is $1.70 M

What is ProQR Therapeutics NV annual accounts payable year-on-year change?

Over the past year, PRQR annual accounts payable has changed by +$1.28 M (+305.19%)

What is ProQR Therapeutics NV quarterly accounts payable?

The current quarterly accounts payable of PRQR is $34.60 K

What is the all time high quarterly accounts payable for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly accounts payable is $2.61 M

What is ProQR Therapeutics NV quarterly accounts payable year-on-year change?

Over the past year, PRQR quarterly accounts payable has changed by $0.00 (0.00%)